Medical devices maker Smith and Nephew said that its Bioventus joint venture with Essex Woodlands is now up and running.
Essex Woodlands, a specialist healthcare growth equity and venture capital firm, pitched in with Smith & Nephew (S&N) to further develop the S&N's Biologics and Clinical Therapies division.
The alliance was announced at the beginning of the year but was subject to obtaining required regulatory approvals and satisfaction of other customary conditions.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Essex Woodlands owns 51% of Bioventus with the rest owned by S&N.
JH
-
ScottishPower launches half-price electricity at weekendsNews ScottishPower is offering 50% off electricity at weekends, which could slash hundreds off your bill. We look at who can get it and how to apply
-
Trump calls “tariff” the “most beautiful word in the dictionary”, but investors may disagreeDonald Trump has promised to slap Mexico, Canada and China with new tariffs on day one of his presidency. What does it mean for the economy and investors?
